公司业务拓展

Search documents
康泰医学:关于投资设立子公司并完成工商注册登记的公告
Zheng Quan Ri Bao· 2025-09-22 14:06
(文章来源:证券日报) 证券日报网讯 9月22日晚间,康泰医学发布公告称,根据公司战略规划,为推动公司业务高质量发展, 完善公司产业布局,进一步提高综合竞争力,公司出资人民币500万元设立全资子公司医电精测技术服 务(秦皇岛)有限公司。公司本次全部以自有资金出资,持股比例为100%。近日,上述子公司完成了 工商注册登记手续,并取得了秦皇岛市市场监督管理局经济技术开发区分局颁发的《营业执照》。 ...
国林科技:公司正稳步推进,不断拓展相关行业的客户群体
Zheng Quan Ri Bao· 2025-09-15 09:09
证券日报网讯国林科技9月15日在互动平台回答投资者提问时表示,公司正稳步推进,不断拓展相关行 业的客户群体,具体客户名称不便透露,敬请谅解。 (文章来源:证券日报) ...
江龙船艇科技股份有限公司2025年半年度报告摘要
Shang Hai Zheng Quan Bao· 2025-08-21 20:00
证券代码:300589 证券简称:江龙船艇 公告编号:2025-043 一、重要提示 本半年度报告摘要来自半年度报告全文,为全面了解本公司的经营成果、财务状况及未来发展规划,投 资者应当到证监会指定媒体仔细阅读半年度报告全文。 所有董事均已出席了审议本报告的董事会会议。 非标准审计意见提示 □适用 √不适用 董事会审议的报告期利润分配预案或公积金转增股本预案 □适用 √不适用 公司计划不派发现金红利,不送红股,不以公积金转增股本。 董事会决议通过的本报告期优先股利润分配预案 □适用 √不适用 二、公司基本情况 1、公司简介 持股5%以上股东、前10名股东及前10名无限售流通股股东参与转融通业务出借股份情况 □适用 √不适用 前10名股东及前10名无限售流通股股东因转融通出借/归还原因导致较上期发生变化 □适用 √不适用 公司是否具有表决权差异安排 ■ 2、主要会计数据和财务指标 公司是否需追溯调整或重述以前年度会计数据 □是 √否 ■ 3、公司股东数量及持股情况 单位:股 ■ □是 √否 4、控股股东或实际控制人变更情况 控股股东报告期内变更 □适用 √不适用 公司报告期控股股东未发生变更。 实际控制人报告期 ...
未来电器: 关于变更公司经营范围及修订《公司章程》的公告
Zheng Quan Zhi Xing· 2025-07-10 10:12
Core Viewpoint - The company, Suzhou Future Electric Co., Ltd., has proposed changes to its business scope and amendments to its Articles of Association to align with its operational development needs [1][4]. Business Scope Change - The company has expanded its business scope to include a wider range of products and services, such as manufacturing and sales of automation equipment, electric power facilities, and various electronic components, among others [1][3]. - The previous business scope included high and low voltage complete equipment, small circuit breakers, and energy metering devices, while the new scope adds items like photovoltaic equipment, software development, and integrated circuit design [1][2][3]. Articles of Association Revision - The Articles of Association have been revised to reflect the new business scope, ensuring compliance with relevant laws and regulations [2][3]. - The company retains the ability to adjust its business scope and operational methods based on market changes and business development needs, subject to necessary approvals [3]. Shareholder Meeting Requirement - The proposed changes and amendments will be submitted for approval at the company's shareholder meeting, where management will be authorized to handle the necessary registration changes [4].
睿智医药:拟1500万元设立全资子公司
news flash· 2025-06-11 11:35
Core Viewpoint - The company plans to invest a total of 15 million yuan using its own funds to establish two wholly-owned subsidiaries in Guangzhou, aiming to expand its business and enhance core competitiveness and profitability [1] Group 1: Investment Details - The company will set up Guangzhou Ruiying Equity Investment Co., Ltd. with a registered capital of 10 million yuan, focusing on equity investment [1] - The second subsidiary, Guangzhou Ruilian Anmei Health Technology Co., Ltd., will have a registered capital of 5 million yuan, engaging in food sales and medical services [1] - The investment has been approved by the company's sixth board of directors at its eighth meeting, and management has been authorized to handle related matters [1] Group 2: Financial Impact - The funding for this investment will come from the company's own resources, ensuring that it will not adversely affect the company's financial status or operational performance [1]